{"id":"https://openalex.org/W4403778160","doi":"https://doi.org/10.1136/rmdopen-2024-004476","title":"Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study","display_name":"Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403778160","doi":"https://doi.org/10.1136/rmdopen-2024-004476","pmid":"https://pubmed.ncbi.nlm.nih.gov/39455065","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11529685"},"language":"en","primary_location":{"id":"doi:10.1136/rmdopen-2024-004476","doi":"https://doi.org/10.1136/rmdopen-2024-004476","is_oa":true,"landing_page_url":"https://doi.org/10.1136/rmdopen-2024-004476","pdf_url":"https://rmdopen.bmj.com/content/10/4/e004476.full.pdf","source":{"id":"https://openalex.org/S2738706341","display_name":"RMD Open","issn_l":"2056-5933","issn":["2056-5933"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://rmdopen.bmj.com/content/10/4/e004476.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042417820","display_name":"Maya H Buch","orcid":"https://orcid.org/0000-0002-8962-5642","observed_orcids":["https://orcid.org/0000-0002-8962-5642"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210159460","display_name":"NIHR Manchester Biomedical Research Centre","ror":"https://ror.org/05njkjr15","country_code":"GB","type":"facility","lineage":["https://openalex.org/I34931013","https://openalex.org/I4210159460"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Maya H Buch","raw_affiliation_strings":["Centre for Musculoskeletal Research, University of Manchester, Manchester, UK","NIHR Manchester Biomedical Research Centre, Manchester, UK","Centre for Musculoskeletal Research, University of Manchester, Manchester, UK maya.buch@manchester.ac.uk"],"raw_orcid":"https://orcid.org/0000-0002-8962-5642","affiliations":[{"raw_affiliation_string":"Centre for Musculoskeletal Research, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"NIHR Manchester Biomedical Research Centre, Manchester, UK","institution_ids":["https://openalex.org/I4210159460"]},{"raw_affiliation_string":"Centre for Musculoskeletal Research, University of Manchester, Manchester, UK maya.buch@manchester.ac.uk","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061411814","display_name":"Daniel Aletaha","orcid":"https://orcid.org/0000-0003-2108-0030","observed_orcids":["https://orcid.org/0000-0003-2108-0030"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Daniel Aletaha","raw_affiliation_strings":["Division of Rheumatology, Medical University of Vienna, Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0003-2108-0030","affiliations":[{"raw_affiliation_string":"Division of Rheumatology, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008811878","display_name":"Bernard G Combe","orcid":"https://orcid.org/0000-0003-4002-1861","observed_orcids":["https://orcid.org/0000-0003-4002-1861"]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bernard G Combe","raw_affiliation_strings":["Rheumatology, Montpellier University, Montpellier, Occitanie, France"],"raw_orcid":"https://orcid.org/0000-0003-4002-1861","affiliations":[{"raw_affiliation_string":"Rheumatology, Montpellier University, Montpellier, Occitanie, France","institution_ids":["https://openalex.org/I19894307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015953107","display_name":"Yoshiya Tanaka","orcid":"https://orcid.org/0000-0002-0807-7139","observed_orcids":["https://orcid.org/0000-0002-0807-7139"]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiya Tanaka","raw_affiliation_strings":["University of Occupational and Environmental Health Japan, Kitakyushu, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0807-7139","affiliations":[{"raw_affiliation_string":"University of Occupational and Environmental Health Japan, Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030926246","display_name":"Roberto Caporali","orcid":"https://orcid.org/0000-0001-6331-8559","observed_orcids":["https://orcid.org/0000-0001-6331-8559"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210113750","display_name":"Istituto Ortopedico Gaetano Pini","ror":"https://ror.org/02brpaf34","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210113750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Caporali","raw_affiliation_strings":["ASST Gaetano Pini-CTO, Milan, Italy","University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASST Gaetano Pini-CTO, Milan, Italy","institution_ids":["https://openalex.org/I4210113750"]},{"raw_affiliation_string":"University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079051965","display_name":"Hendrik Schulze\u2010Koops","orcid":"https://orcid.org/0000-0002-1681-491X","observed_orcids":["https://orcid.org/0000-0002-1681-491X"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hendrik Schulze-Koops","raw_affiliation_strings":["Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig Maximilian University of Munich, Munich, Germany"],"raw_orcid":"https://orcid.org/0000-0002-1681-491X","affiliations":[{"raw_affiliation_string":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig Maximilian University of Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083314956","display_name":"Tsutomu Takeuchi","orcid":"https://orcid.org/0000-0003-1111-8218","observed_orcids":["https://orcid.org/0000-0003-1111-8218"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsutomu Takeuchi","raw_affiliation_strings":["Keio University, Tokyo, Japan","Saitama Medical University, Saitama, Japan"],"raw_orcid":"https://orcid.org/0000-0003-1111-8218","affiliations":[{"raw_affiliation_string":"Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]},{"raw_affiliation_string":"Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107869788","display_name":"Jacques\u2010Eric Gottenberg","orcid":"https://orcid.org/0000-0002-9469-946X","observed_orcids":["https://orcid.org/0000-0002-9469-946X"]},"institutions":[{"id":"https://openalex.org/I4210145324","display_name":"H\u00f4pitaux Universitaires de Strasbourg","ror":"https://ror.org/04bckew43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145324"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jacques-Eric Gottenberg","raw_affiliation_strings":["Rheumatology, Strasbourg University Hospitals, Strasbourg, Grand Est, France"],"raw_orcid":"https://orcid.org/0000-0002-9469-946X","affiliations":[{"raw_affiliation_string":"Rheumatology, Strasbourg University Hospitals, Strasbourg, Grand Est, France","institution_ids":["https://openalex.org/I4210145324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085520437","display_name":"Ricardo Blanco","orcid":"https://orcid.org/0000-0003-2344-2285","observed_orcids":["https://orcid.org/0000-0003-2344-2285"]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]},{"id":"https://openalex.org/I4210113075","display_name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla","ror":"https://ror.org/025gxrt12","country_code":"ES","type":"other","lineage":["https://openalex.org/I13134134","https://openalex.org/I4210113075"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ricardo Blanco","raw_affiliation_strings":["Immunopathology group, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL, Santander, Cantabria, Spain"],"raw_orcid":"https://orcid.org/0000-0003-2344-2285","affiliations":[{"raw_affiliation_string":"Immunopathology group, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL, Santander, Cantabria, Spain","institution_ids":["https://openalex.org/I4210099858","https://openalex.org/I4210113075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090277186","display_name":"Patrick Verschueren","orcid":"https://orcid.org/0000-0002-0340-3580","observed_orcids":["https://orcid.org/0000-0002-0340-3580"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Patrick Verschueren","raw_affiliation_strings":["Department of Rheumatology, KU Leuven and University Hospital Leuven, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-0340-3580","affiliations":[{"raw_affiliation_string":"Department of Rheumatology, KU Leuven and University Hospital Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040245240","display_name":"Anna Zubrzycka\u2010Sienkiewicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Zubrzycka-Sienkiewicz","raw_affiliation_strings":["ARS Rheumatica, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARS Rheumatica, Warsaw, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Francesco De Leonardis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco De Leonardis","raw_affiliation_strings":["Galapagos GmbH, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galapagos GmbH, Basel, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017909182","display_name":"Edmund V Ekoka Omoruyi","orcid":"https://orcid.org/0009-0006-5893-3630","observed_orcids":["https://orcid.org/0009-0006-5893-3630"]},"institutions":[{"id":"https://openalex.org/I85459889","display_name":"Galapagos (Belgium)","ror":"https://ror.org/04e4j5d46","country_code":"BE","type":"company","lineage":["https://openalex.org/I85459889"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Edmund V Ekoka Omoruyi","raw_affiliation_strings":["Galapagos NV, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galapagos NV, Mechelen, Belgium","institution_ids":["https://openalex.org/I85459889"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012523958","display_name":"Vijay Rajendran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85459889","display_name":"Galapagos (Belgium)","ror":"https://ror.org/04e4j5d46","country_code":"BE","type":"company","lineage":["https://openalex.org/I85459889"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Vijay Rajendran","raw_affiliation_strings":["Galapagos NV, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galapagos NV, Mechelen, Belgium","institution_ids":["https://openalex.org/I85459889"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018678002","display_name":"Paul Emery","orcid":"https://orcid.org/0000-0002-7429-8482","observed_orcids":["https://orcid.org/0000-0002-7429-8482","https://orcid.org/0000-0002-4136-3436"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Emery","raw_affiliation_strings":["NIHR Leeds Biomedical Research Centre, Leeds, UK","University of Leeds, Leeds, UK"],"raw_orcid":"https://orcid.org/0000-0002-7429-8482","affiliations":[{"raw_affiliation_string":"NIHR Leeds Biomedical Research Centre, Leeds, UK","institution_ids":[]},{"raw_affiliation_string":"University of Leeds, Leeds, UK","institution_ids":["https://openalex.org/I130828816"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":16,"corresponding_author_ids":["https://openalex.org/A5042417820"],"corresponding_institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210159460"],"apc_list":{"value":1950,"currency":"GBP","value_usd":2391},"apc_paid":{"value":1950,"currency":"GBP","value_usd":2391},"fwci":2.2192,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.86699663,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"10","issue":"4","first_page":"e004476","last_page":"e004476"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/filgotinib","display_name":"filgotinib","score":1.0},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.996999979019165},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/jak1-inhibitor","display_name":"JAK1 inhibitor","score":0.6610000133514404},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7239999771118164},{"id":"https://openalex.org/keywords/sustained-remission","display_name":"sustained remission","score":0.7049999833106995},{"id":"https://openalex.org/keywords/acr20-response","display_name":"ACR20 response","score":0.7440000176429749},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.5740000009536743},{"id":"https://openalex.org/keywords/inadequate-response-to-methotrexate","display_name":"inadequate response to methotrexate","score":0.847000002861023},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9794516563415527},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7900547385215759},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.7536929845809937},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.5737212896347046},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4929161071777344},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.4873379170894623},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3273146152496338},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2986927032470703},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1136/rmdopen-2024-004476","doi":"https://doi.org/10.1136/rmdopen-2024-004476","is_oa":true,"landing_page_url":"https://doi.org/10.1136/rmdopen-2024-004476","pdf_url":"https://rmdopen.bmj.com/content/10/4/e004476.full.pdf","source":{"id":"https://openalex.org/S2738706341","display_name":"RMD Open","issn_l":"2056-5933","issn":["2056-5933"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11529685","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11529685","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11529685/pdf/rmdopen-10-4.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"Text"},{"id":"pmid:39455065","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39455065","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD open","raw_type":"Journal Article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:20.500.12942/760910","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/20.500.12942/760910","pdf_url":"https://lirias.kuleuven.be/retrieve/c111a3a2-cdff-43d9-bc96-9af250943fae","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RMD Open, vol. 10 (4), Art.No. ARTN e004476","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repositorio.unican.es:10902/35163","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10902/35163","pdf_url":"https://repositorio.unican.es/xmlui/bitstream/10902/35163/3/EfficacySafetyFilgotinib.pdf","source":{"id":"https://openalex.org/S4306400398","display_name":"UCrea (University of Cantabria)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13134134","host_organization_name":"Universidad de Cantabria","host_organization_lineage":["https://openalex.org/I13134134"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RMD open, 2024, 12, e004476","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:876c49e5e08a4163a919ba3850e5bc79","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/876c49e5e08a4163a919ba3850e5bc79","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RMD Open, Vol 10, Iss 4 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/rmdopen-2024-004476","doi":"https://doi.org/10.1136/rmdopen-2024-004476","is_oa":true,"landing_page_url":"https://doi.org/10.1136/rmdopen-2024-004476","pdf_url":"https://rmdopen.bmj.com/content/10/4/e004476.full.pdf","source":{"id":"https://openalex.org/S2738706341","display_name":"RMD Open","issn_l":"2056-5933","issn":["2056-5933"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RMD Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320318316","display_name":"Celltrion","ror":"https://ror.org/05k84m754"},{"id":"https://openalex.org/F4320319293","display_name":"Gal\u00e1pagos","ror":"https://ror.org/04e4j5d46"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320328674","display_name":"Nordic Pharma Group","ror":null},{"id":"https://openalex.org/F4320332195","display_name":"Samsung","ror":"https://ror.org/04w3jy968"},{"id":"https://openalex.org/F4320333002","display_name":"Pfizer Japan","ror":"https://ror.org/05pm71w80"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320333624","display_name":"Eli Lilly Japan","ror":"https://ror.org/01sv7f575"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403778160.pdf","grobid_xml":"https://content.openalex.org/works/W4403778160.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1523138578","https://openalex.org/W1925000895","https://openalex.org/W2154662505","https://openalex.org/W2313050209","https://openalex.org/W2775837997","https://openalex.org/W2962938985","https://openalex.org/W3097462853","https://openalex.org/W3118646829","https://openalex.org/W3124339251","https://openalex.org/W3128990629","https://openalex.org/W3164420148","https://openalex.org/W3171798423","https://openalex.org/W3171954900","https://openalex.org/W3210178764","https://openalex.org/W4210529991","https://openalex.org/W4229006278","https://openalex.org/W4229044390","https://openalex.org/W4231972505","https://openalex.org/W4307228818","https://openalex.org/W4308769923","https://openalex.org/W4366831698","https://openalex.org/W4379517712","https://openalex.org/W4392768049"],"related_works":["https://openalex.org/W7037486900","https://openalex.org/W4395076799","https://openalex.org/W7039684039","https://openalex.org/W4224308161","https://openalex.org/W2807884126","https://openalex.org/W2950426289","https://openalex.org/W7055928615","https://openalex.org/W4205716810","https://openalex.org/W3019770355","https://openalex.org/W2939779191"],"abstract_inverted_index":{"BACKGROUND:":[0],"Janus":[1,34],"kinase":[2,35],"inhibitors":[3],"are":[4],"an":[5,136,154],"effective":[6],"option":[7],"for":[8,42],"achieving":[9],"sustained":[10,249],"remission":[11,125,179],"or":[12,69,76,78,83,245,262],"low":[13],"disease":[14],"activity":[15],"in":[16,39,216,255],"patients":[17,64,134,188,217,256],"with":[18,129,135,190,227,264],"rheumatoid":[19],"arthritis":[20],"(RA)":[21],"following":[22],"inadequate":[23,137],"response":[24,100,138],"to":[25,91,139,252],"conventional":[26],"synthetic":[27],"disease-modifying":[28],"anti-rheumatic":[29],"drugs.":[30],"Filgotinib":[31],"is":[32],"a":[33],"1-preferential":[36],"inhibitor":[37],"available":[38],"two":[40],"doses":[41],"moderate-to-severe":[43],"RA.":[44],"We":[45],"report":[46],"the":[47,56,228],"long-term":[48,58],"efficacy":[49,212,250],"and":[50,123,127,142,150,163,172,185,196,200,203,221,241],"safety":[51,230,267],"of":[52,97,109,115,121,165,187,232],"filgotinib.":[53,233],"METHODS:":[54],"In":[55,133,235],"ongoing":[57],"extension":[59],"study":[60],"FINCH":[61,73,219,236,259],"4":[62],"(NCT03025308),":[63],"continue":[65],"filgotinib":[66,80,147,169,193,238],"200":[67,81,148,170,194,239],"mg":[68,71,82,85,149,152,171,195,240,243],"100":[70,84,151,173,197,242],"from":[72,218,258],"1,":[74,260],"2":[75,220,261],"3":[77],"receive":[79],"de":[86,145,191,246],"novo.":[87],"Efficacy":[88],"assessments":[89],"up":[90,251],"week":[92,157,176,253],"156":[93,254],"include":[94],"American":[95],"College":[96],"Rheumatology":[98],"20%":[99],"(ACR20),":[101],"Disease":[102,112,118],"Activity":[103,113,119],"Score":[104],"28":[105],"using":[106],"C-reactive":[107],"protein":[108],"<2.6,":[110],"Clinical":[111],"Index":[114,120],"\u22642.8,":[116],"Simplified":[117],"\u22643.3":[122],"Boolean":[124,178,206],"(1.0":[126],"2.0)":[128],"non-responder":[130],"imputation.":[131],"RESULTS:":[132],"methotrexate,":[140],"60.2%":[141],"54.6%":[143],"receiving":[144],"novo":[146,192],"had":[153],"ACR20":[155],"at":[156],"156,":[158,177],"respectively,":[159,199],"as":[160],"did":[161],"67.3%":[162],"59.5%":[164],"those":[166],"who":[167],"continued":[168],"mg.":[174],"At":[175],"1.0":[180],"was":[181],"achieved":[182],"by":[183,201],"18.8%":[184],"15.4%":[186],"treated":[189],"mg,":[198],"21.1%":[202],"18.5%":[204],"when":[205],"2.0":[207],"criteria":[208],"were":[209,214,225],"applied.":[210],"Similar":[211],"data":[213,224],"seen":[215],"3.":[222],"Safety":[223],"consistent":[226],"known":[229],"profile":[231],"CONCLUSION:":[234],"4,":[237],"(continuous":[244],"novo)":[247],"demonstrated":[248],"enrolled":[257],"3,":[263],"no":[265],"unexpected":[266],"results.":[268]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-10-26T00:00:00"}